Polomar Health amends license with Pinata; adds pharmacy sub, sets royalties of 10-20%

Polomar Health Services, Inc.

Amended license covers metformin (10% royalty), semaglutide/liraglutide (20%), sumatriptan/sildenafil (15%).
License is worldwide, non-exclusive, perpetual; may be terminated with 180 days notice or for uncured breach.
Polomar Specialty Pharmacy, a wholly-owned Florida subsidiary, added as a licensee.
Pinata is an affiliate of CWR 1 LLC, Polomar's majority shareholder (common ownership).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.